Treatment disagreement gets ugly in Western Australia


The parents of a six-year-old West Australian boy have spoken of their distress after a Perth hospital obtained a court order to force chemotherapy on the child.

Angela Kiszko and Colin Strachan – the parents of Oshin Kiszko, who has been diagnosed with advanced brain cancer – believe that their son should not have to undergo chemotherapy, as it is not worth the suffering and risks, which can include long-term intellectual impairment. Instead they asked for palliative care.

Yet earlier this month, a West Australian Family Court ratified the decision of a Princess Margaret Hospital (PMH) ethics committee to enforce the treatment, despite Kiszko and Strachan’s refusal.

Doctors said that the child’s brain tumour was on the cusp of an "irretrievable progression", and that the PMH peadiatric oncology team needed to commence treatment immediately.

The ethics committee, though initially divided, decided that the 'burdens and benefits equation' clearly fell in favour of active treatment.
Ms Kiszko had requested that doctors take a palliative option with reduced chemotherapy, but this was rejected by doctors at PMH.

Australian Medical Association WA president Michael Gannon has defended the hospital, saying the oncology unit at PMH was an outstanding one in a global context and he said no doctor would move to see such a treatment enforced without significant consultation.

"This is rare, extremely unusual and would weigh heavily on the individual clinicians involved," he told a local radio station. "It is something they would almost certainly discuss with their colleagues."

 




MORE ON THESE TOPICS | Australia, clinical ethics, informed consent

This article is published by Xavier Symons and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 
comments powered by Disqus